Scripps Health announced Wednesday that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute.
The funding will advance clinical trials of wireless biosensor systems, the creation of rapid pharmacogenomic diagnostic tests that can be administered in retail stores, and the development of apps and embedded sensors for tracking and predicting heart attacks, Type 1 diabetes and certain types of cancer.
"The combination of wireless technologies, sensors, diagnostics and DNA sequencing tools offers unparalleled opportunities to dramatically impact health care,” said Dr. Paul E. Jacobs, Qualcomm Inc.'s chairman and CEO and Qualcomm Foundation chair. “The Qualcomm Foundation is proud to support this endeavor – bringing breakthrough technologies to the field of medicine to improve patient care."
The Scripps Translational Science Institute was established by Scripps Health in collaboration with various parties to support the development of breakthrough digital technologies designed to revolutionize the practice of medicine.
The Qualcomm Foundation was established in 2010 by Qualcomm Inc. (Nasdaq: QCOM) to develop and strengthen communities worldwide through the philanthropic support of inspirational and innovative programs that serve diverse populations.
9888 Genessee Ave.
La Jolla, CA 92037